(Total Views: 217)
Posted On: 03/23/2018 1:55:56 PM
Post# of 72436
Quote:
An undeniable value at these prices. An amazing opportunity for any one not covered or well-positioned. Purchases at this level will be well-rewarded in the coming years. The price could easily rebound with no news.
It's pretty trivial to value the pipeline significantly above the current price:
Brilacidin Platform $1.00/share
Prurisol $0.75/share
Kevetrin $0.50/share
Total $2.25/share (300% of today's price)
This is just a conservative guestimate at today's value with none of the pending news. Risk/reward seems very low at this point.
I put this forth about 10 months ago. The only difference between then and now is that we completed B-OM, have no SAEs on Prurisol, and showed Kevetrin to modulate p53 in humans.
And, of course, $2.25/share is now 450% of today's price rather than 300%.
The value here is incredible. Truly a once in a lifetime opportunity.
Go IPIX!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.